Concentraciones plasmáticas de digoxina en cuatro esquemas terapéuticos de uso común en la práctica clínica

Background: The different therapeutic schedules used for the prescription of digoxin have little theoretical support. Aim: To measure digoxin plasma levels in patients using four different prescription schedules. Patients and methods: Four groups of patients were studied. Group I corresponded to 56...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Reinbach H,Rolando, Villa Z,Lorenzo, Giraudo T,Paolo, Venegas A,Reinaldo, Fernández R,Pola
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2003
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003000400004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872003000400004
record_format dspace
spelling oai:scielo:S0034-988720030004000042004-12-13Concentraciones plasmáticas de digoxina en cuatro esquemas terapéuticos de uso común en la práctica clínicaReinbach H,RolandoVilla Z,LorenzoGiraudo T,PaoloVenegas A,ReinaldoFernández R,Pola Cardiotonic agents Digoxin Pharmacokinetics Background: The different therapeutic schedules used for the prescription of digoxin have little theoretical support. Aim: To measure digoxin plasma levels in patients using four different prescription schedules. Patients and methods: Four groups of patients were studied. Group I corresponded to 56 patients taking digoxin 0.25 mg/day, from Monday to Friday. Group II corresponded to 30 patients taking digoxin 0.25 mg/day, from Monday to Saturday. Group III corresponded to 53 patients taking digoxin 0.25 mg/day continuosly. Group IV corresponded to 36 patients taking digoxin 0.125 mg/day continuosly. Plasma digoxin levels were measured in two consecutive Mondays before taking the daily dose of the drug. Serum creatinine was also measured and creatinine clearance was calculated. The therapeutic plasma concentration range was set between 0.5 and 2 ng/ml. Results: Mean plasma digoxin levels were 1.15±0.8 ng/ml in group I, 1.4±0.55 ng/ml in group II, 1.68±0.7 ng/ml in group III and 1.14±0.43 ng/ml in group IV. 93% of patients in group I, 80% of patients in group II, 75% of patients in group III and 94% of patients in group IV had therapeutic digoxin levels. A low creatinine clearance, an age over 65 and interactions with other drugs were risk factors associated with supratherapeutic levels, mostly seen in group II and group III with 20% and 24% respectively. Conclusions: Most patients using digoxin with different therapeutic schedules had plasma drug levels within the therapeutic range (Rev Méd Chile 2003; 131: 373-80).info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.131 n.4 20032003-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003000400004es10.4067/S0034-98872003000400004
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Cardiotonic agents
Digoxin
Pharmacokinetics
spellingShingle Cardiotonic agents
Digoxin
Pharmacokinetics
Reinbach H,Rolando
Villa Z,Lorenzo
Giraudo T,Paolo
Venegas A,Reinaldo
Fernández R,Pola
Concentraciones plasmáticas de digoxina en cuatro esquemas terapéuticos de uso común en la práctica clínica
description Background: The different therapeutic schedules used for the prescription of digoxin have little theoretical support. Aim: To measure digoxin plasma levels in patients using four different prescription schedules. Patients and methods: Four groups of patients were studied. Group I corresponded to 56 patients taking digoxin 0.25 mg/day, from Monday to Friday. Group II corresponded to 30 patients taking digoxin 0.25 mg/day, from Monday to Saturday. Group III corresponded to 53 patients taking digoxin 0.25 mg/day continuosly. Group IV corresponded to 36 patients taking digoxin 0.125 mg/day continuosly. Plasma digoxin levels were measured in two consecutive Mondays before taking the daily dose of the drug. Serum creatinine was also measured and creatinine clearance was calculated. The therapeutic plasma concentration range was set between 0.5 and 2 ng/ml. Results: Mean plasma digoxin levels were 1.15±0.8 ng/ml in group I, 1.4±0.55 ng/ml in group II, 1.68±0.7 ng/ml in group III and 1.14±0.43 ng/ml in group IV. 93% of patients in group I, 80% of patients in group II, 75% of patients in group III and 94% of patients in group IV had therapeutic digoxin levels. A low creatinine clearance, an age over 65 and interactions with other drugs were risk factors associated with supratherapeutic levels, mostly seen in group II and group III with 20% and 24% respectively. Conclusions: Most patients using digoxin with different therapeutic schedules had plasma drug levels within the therapeutic range (Rev Méd Chile 2003; 131: 373-80).
author Reinbach H,Rolando
Villa Z,Lorenzo
Giraudo T,Paolo
Venegas A,Reinaldo
Fernández R,Pola
author_facet Reinbach H,Rolando
Villa Z,Lorenzo
Giraudo T,Paolo
Venegas A,Reinaldo
Fernández R,Pola
author_sort Reinbach H,Rolando
title Concentraciones plasmáticas de digoxina en cuatro esquemas terapéuticos de uso común en la práctica clínica
title_short Concentraciones plasmáticas de digoxina en cuatro esquemas terapéuticos de uso común en la práctica clínica
title_full Concentraciones plasmáticas de digoxina en cuatro esquemas terapéuticos de uso común en la práctica clínica
title_fullStr Concentraciones plasmáticas de digoxina en cuatro esquemas terapéuticos de uso común en la práctica clínica
title_full_unstemmed Concentraciones plasmáticas de digoxina en cuatro esquemas terapéuticos de uso común en la práctica clínica
title_sort concentraciones plasmáticas de digoxina en cuatro esquemas terapéuticos de uso común en la práctica clínica
publisher Sociedad Médica de Santiago
publishDate 2003
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003000400004
work_keys_str_mv AT reinbachhrolando concentracionesplasmaticasdedigoxinaencuatroesquemasterapeuticosdeusocomunenlapracticaclinica
AT villazlorenzo concentracionesplasmaticasdedigoxinaencuatroesquemasterapeuticosdeusocomunenlapracticaclinica
AT giraudotpaolo concentracionesplasmaticasdedigoxinaencuatroesquemasterapeuticosdeusocomunenlapracticaclinica
AT venegasareinaldo concentracionesplasmaticasdedigoxinaencuatroesquemasterapeuticosdeusocomunenlapracticaclinica
AT fernandezrpola concentracionesplasmaticasdedigoxinaencuatroesquemasterapeuticosdeusocomunenlapracticaclinica
_version_ 1718436086975299584